about
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearanceThe FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.Targeting Neuroinflammation to Treat Alzheimer's Disease.Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6.The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8125-9027
@en
name
Xianyuan Xiang
@ast
Xianyuan Xiang
@en
Xianyuan Xiang
@es
Xianyuan Xiang
@nl
type
label
Xianyuan Xiang
@ast
Xianyuan Xiang
@en
Xianyuan Xiang
@es
Xianyuan Xiang
@nl
prefLabel
Xianyuan Xiang
@ast
Xianyuan Xiang
@en
Xianyuan Xiang
@es
Xianyuan Xiang
@nl
P106
P31
P496
0000-0002-8125-9027